Thyroid nodules in pediatrics: Which ones can be left alone, which ones must be investigated, when and how

JCRPE Journal of Clinical Research in Pediatric Endocrinology

Volumn 5, Issue SUPPL.1, 2013, Pages 57-69

  Corrias, Andrea ^a   Mussa, Alessandro ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Children; Pediatrics; Thyroid cancer; Thyroid nodules

Indexed keywords

BETA CATENIN; CALCITONIN; CD44V6 ANTIGEN; CYTOKERATIN 19; DNA TOPOISOMERASE (ATP HYDROLYSING); GALECTIN 3; KERATAN SULFATE; LEVOTHYROXINE; LIOTHYRONINE; MITOGEN ACTIVATED PROTEIN KINASE; PENTAGASTRIN; PLAKOGLOBIN; TELOMERASE; THYROTROPIN; THYROXINE; TRANSCRIPTION FACTOR ETS 1; TRANSCRIPTION FACTOR FRA 1; UVOMORULIN;

ADENOMA; AUTOIMMUNE THYROIDITIS; CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL HYPOTHYROIDISM; CYTOLOGY; DISEASE ASSOCIATION; EARLY DIAGNOSIS; ECHOGRAPHY; ELASTOGRAPHY; ENDOCRINE TUMOR; FINE NEEDLE ASPIRATION BIOPSY; FREE THYROXINE INDEX; GENE MUTATION; HISTOLOGY; HUMAN; HYPERTHYROIDISM; IMMUNOCYTOCHEMISTRY; IONIZING RADIATION; LABORATORY TEST; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; THYROID CANCER; THYROID CARCINOMA; THYROID NODULE;

CHILD; HUMANS; THYROID NODULE;

EID: 84874531502     PISSN: 13085727     EISSN: 13085735     Source Type: Journal    
DOI: 10.4274/Jcrpe.853     Document Type: Review

References (95)

1. Dean DS, Gharib H. Epidemiology of thyroid nodules. Best Pract Res Clin Endocrinol Metab 2008;22:901-911.
2. Rallison ML, Dobyns BM, Keating FR Jr, Rall JE, Tyler FH. Thyroid nodularity in children. JAMA 1975;233:1069-1072.
3. Corrias A, Mussa A, Baronio F, Arrigo T, Salerno M, Segni M, Vigone MC, Gastaldi R, Zirilli G, Tuli G, Beccaria L, Iughetti L, Einaudi S, Weber G, De Luca F, Cassio A; Study Group for Thyroid Diseases of Italian Society for Pediatric Endocrinology and Diabetology (SIEDP/ISPED). Diagnostic features of thyroid nodules in pediatrics. Arch Pediatr Adolesc Med 2010;164:714-719.
4. Niedziela M. Pathogenesis, diagnosis and management of thyroid nodules in children. Endocr Relat Cancer 2006;13:427-453.
5. Aghini-Lombardi, Antonangeli L, Martino E, Vitti P, Maccherini D, Leoli F, Rago T, Grasso L, Valeriano R, Balestrieri A, Pinchera A. The spectrum of hyroid disorders in an iodine-deficient community:the Pescopagano survey. J Clin Endocrinol Metab 1999;84:561-566.
6. Dinauer CA, Breuer C, Rivkees SA. Differentiated thyroid cancer in children:diagnosis and management. Curr Opin Oncol 2008;20:59-65.
7. Duffy BJ Jr, Fitzgerald PJ. Thyroid cancer in childhood and adolescence; a report on 28 cases. Cancer 1950;3:1018-1032.
8. Wang C, Crapo LM. The epidemiology of thyroid disease and implications for screening. Endocrinol Metab Clin North Am 1997;26:189-218.
9. Halac I, Zimmerman D. Thyroid nodules and cancers in children. Endocrinol Metab Clin North Am 2005;34:725-744.
10. Dailey ME, Lindsay S, Skahen R. Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland. AMA Arch Surg 1955;70:291-297.
11. Corrias A, Cassio A, Weber G, Mussa A, Wasniewska M, Rapa A, Gastaldi R, Einaudi S, Baronio, Vigone MC, Messina MF, Bal M, Bona G, de Sanctis C; Study Group for Thyroid Diseases of Italian Society for Pediatric Endocrinology and Diabetology (SIEDP/ISPED). Thyroid nodules and cancer in children and adolescents affected by autoimmune thyroiditis. Arch Pediatr Adolesc Med 2008;162:526-531.
12. Sigurdson AJ, Ronckers CM, Mertens AC, Stovall M, Smith SA, Liu Y, Berkow RL, Hammond S, Neglia JP, Meadows AT, Sklar CA, Robison LL, Inskip PD. Primary thyroid cancer after a first tumors in childhood the Childhood Cancer Survivor Study): a nested case control study. Lancet 2005;365:2014-2023.
13. Scott MD, Crawford JD. Solitary thyroid nodules in childhood: is the incidence of thyroid carcinoma declining? Pediatrics 1976;58:521-525.
14. White AK, Smith RJ. Thyroid nodules in children. Otolaryngol Head Neck Surg 1986;95:70-75.
15. Rabes HM, Demidchik EP, Sidorow JD, Lengfelder E, Beimfohr C, Hoelzel D, Klugbauer S. Pattern of radiation-induced RET and NTRK1 rearrangements in 191 post-chernobyl papillary thyroid carcinomas: biological, phenotypic, and clinical implications. Clin Cancer Res 2000;6:1093-1103.
16. Nikiforov Y, Gnepp DR. Pediatric thyroid cancer after the Chernobyl disaster. Pathomorphological study of 84 cases (1991-1992) from the R Epublic of Belarus. Cancer 1994;74:748-766.
17. Pacini D, Vorontsova T, Demidchik EP, Molinaro E, Agate L, Romei C, Shavrova E, Cherstvoy ED, Ivashkevitch Y, Kuchinskaya E, Schlumberger M, Ronga G, Filesi M, Pinchera A. Post-Chernobyl thyroid carcinoma in Belarus children and adolescents: comparison with naturally occurring thyroid carcinoma in Italy and France. J Clin Endocrinol Metab 1997;82:3563-3569.
18. Brignardello E, Corrias A, Isolato G, Palestini N, Cordero di Montezemolo L, Fagioli F, Boccuzzi G. Ultrasound screening for thyroid carcinoma in childhood cancer survivors: a case series. J Clin Endocrinol Metab 2008;93:4840-4843. Epub 2008 Sep 23
19. Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM, Schneider AB, Tucker MA, Boice JD Jr. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 1995;141:259-277.
20. Acharya S, Sarafoglou K, LaQuaglia M, Lindsley S, Gerald W, Wollner N, Tan C, Sklar C. Thyroid neoplasms after therapeutic radiation for malignancies during childhood or adolescence. Cancer 2003;97:2397-2403.
21. Cohen A, Rovelli A, Merlo DF, van Lint MT, Lanino E, Bresters D, Ceppi M, Bocchini V, Tichelli A, Socié G. Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: an EBMT Late Effects Working Party Study. J Clin Oncol 2007;25:2449-2454.
22. Yamashita S, Saenko V. Mechanisms of Disease: molecular genetics of childhood thyroid cancers. Nat Clin Pract Endocrinol Metab 2007;3:422-429.
23. Gandhi M, Evdokimova V, Nikiforov YE. Mechanisms of chromosomal rearrangements in solid tumours: the model of papillary thyroid carcinoma. Mol Cell Endocrinol 2010;321:36-43. Epub 2009 Sep 18
24. Collins BJ, Chiappetta G, Schneider AB, Santoro M, Pentimalli B, Fogelfeld L, Gierlowski T, Shore-Freedman E, Jaffe G, Fusco A. RET expression in papillary thyroid cancer from patients irradiated in childhood for benign conditions. J Clin Endocrinol Metab 2002;87:3941-3946.
25. Harach HR, Soubeyran I, Brown A, Bonneau D, Longy M. Thyroid pathologic findings in patients with Cowden disease. Ann Diagn Pathol 1999;3:331-340.
26. Congedo V, Celi FS. Thyroid disease in patients with McCune-Albright syndrome. Pediatr Endocrinol Rev 2007;4:429-433.
27. Hamilton CR Jr, Maloof F. Unusual types of hyperthyroidism. Medicine (Baltimore) 1973;52:195-215.
28. Massoll N, Mazzaferri EL. Diagnosis and management of medullary thyroid carcinoma. Clin Lab Med 2004;24:49-83.
29. Raue F, Frank-Raue K. Multiple endocrine neoplasia type 2: 2007 update. Horm Res 2007;68:101-104. Epub 2007 Dec 10
30. Kapila K, Pathan SK, George SS, Haji BE, Das DK, Qadan LR. Fine needle aspiration cytology of the thyroid in children and adolescents: experience with 792 aspirates. Acta Cytol 2010;54:569-574.
31. Eng C, Clayton D, Schuffenecker I, Lenoir G, Cote G, Gagel R, van Amstel HK, Lips CJ, Nishisho I, Takai SI, Marsh DJ, Robinson BG, Frank-Raue K, Raue G, Xue, Noll WW, Romei C, Pacini F, Fink M, Niederle B, Zedenius J, Nordenskjöld M, Komminoth P, Hendy GN, Mulligan LM, et al. The relationship between specific RET protooncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. JAMA 1996;276:1575-1579.
32. Learoyd DL, Marsh DJ, Richardson AL, Twigg SM, Delbridge L, Robinson BG. Genetic testing for familial cancer. Consequences of RET proto-oncogene mutation analysis in multiple endocrine neoplasia, type 2. Arch Surg 1997;132:1022-1025.
33. Fialkowski EA, Moley JF. Current approaches to medullary thyroid carcinoma, sporadic and familial. J Surg Oncol 2006;94:737-747.
34. Mazzaferri EL. Management of a solitary thyroid nodule. N Engl J Med 1993;328:553-559.
35. Brink JS, van Heerden JA, McIver B, Salomao DR, Farley DR, Grant CS, Thompson GB, Zimmerman D, Hay ID. Papillary thyroid cancer with pulmonary metastases in children: long-term prognosis. Surgery 2000;128:881-886.
36. Corrias A, Einaudi S, Chiorboli E, Weber G, Crinò A, Andreo M, Cesaretti G, de Sanctis L, Messina MF, Segni M, Cicchetti M, Vigone M, Pasquino AM, Spera S, de Luca F, Mussa GC, Bona G. Accuracy of fine needle aspiration biopsy of thyroid nodules in detecting malignancy in childhood: comparison with conventional clinical, laboratory, and imaging approaches. J Clin Endocrinol Metab 2001;86:4644-4648.
37. Viswanathan K, Gierlowski TC, Schneider AB. Childhood thyroid cancer. Characteristics and long-term outcome in children irradiated for benign conditions of the head and neck. Arch Pediatr Adolesc Med 1994;148:260-265.
38. Chiu HK, Sanda S, Fechner PY, Pihoker C. Correlation of TSH with the risk of paediatric thyroid carcinoma. Clin Endocrinol (Oxf) 2012;77:316-322.
39. Fiore E, Vitti P. Serum TSH and risk of papillary thyroid cancer in nodular thyroid disease. J Clin Endocrinol Metab. 2012;97:1134-1145. Epub 2012 Jan 25
40. Fiore E, Rago T, Provenzale MA, Scutari M, Ugolini C, Basolo C, Di Coscio G, Berti, Grasso L, Elisei R, Pinchera A, Vitti P. Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role. Endocr Relat Cancer 2009;16:1251-1260. Epub 2009 Jun 15
41. Fiore E, Rago T, Provenzale MA, Scutari M, Ugolini C, Basolo V, Di Coscio G, Miccoli, Grasso L, Pinchera A, Vitti P. L-thyroxine treated patients with nodular goiter have lower serum TSH and lower frequency of papillary thyroid cancer: results of a cross sectional study on 27 914 patients. Endocr Relat Cancer 2010;17:231-239.
42. Mondal HP, Sen S, Sasmal S, Ghosal PK, Mukhopadhyay SK, Mukhopadhyay M. Clinicopathological correlation of serum TSH in patients with thyroid nodule. J Indian Med Assoc 2011;109:330-338.
43. Haymart MR, Repplinger DJ, Leverson GE, Elson DF, Sippel RS, Jaume JC, Chen H. Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. J Clin Endocrinol Metab 2008;93:809-814. Epub 2007 Dec 26
44. Boelaert K. The association between serum TSH concentration and thyroid cancer. Endocr Relat Cancer 2009;16:1065-1072. Epub 2009 Jul 20
45. Tonacchera M, Pinchera A, Vitti P. Assessment of nodular goitre. Best Pract Res Clin Endocrinol Metab 2010;24:51-61.
46. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19:1167-1214.
47. Daniels GH. Screening for medullary thyroid carcinoma with serum calcitonin measurements in patients with thyroid nodules in the United States and Canada. Thyroid 2011;21:1199-1207.
48. Costante G, Meringolo D, Durante C, Bianchi D, Nocera M, Tumino S, Crocetti U, Attard M, Maranghi M, Torlontano M, Filetti S. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J Clin Endocrinol Metab 2007;92:450-455. Epub 2006 Nov 21
49. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W; European Thyroid Cancer Taskforce. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006;154:787-803.
50. Costante G, Filetti S. Early diagnosis of medullary thyroid carcinoma: is systematic calcitonin screening appropriate in patients with nodular thyroid disease? Oncologist 2011;16:49-52. Epub 2011 Jan 6
51. Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedüs L, Vitti P; AACE/AME/ETA Task Force on Thyroid Nodules. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association Medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations. Endocr Pract 2010;16:468-475.
52. Elisei R. Routine serum calcitonin measurement in the evaluation of thyroid nodules. Best Pract Res Clin Endocrinol Metab 2008;22:941-953.
53. Massaro F, Dolcino M, Degrandi R, Ferone D, Mussap M, Minuto F, Giusti M. Calcitonin assay in wash-out fluid after fine-needle aspiration biopsy in patients with a thyroid nodule and border-line value of the hormone. J Endocrinol Invest 2009;32:308-312.
54. Costante G, Durante C, Francis Z, Schlumberger M, Filetti S. Determination of calcitonin levels in C-cell disease: clinical interest and potential pitfalls. Nat Clin Pract Endocrinol Metab 2009;5:35-44.
55. Kudo T, Miyauchi A, Ito Y, Takamura Y, Amino N, Hirokawa M. Diagnosis of medullary thyroid carcinoma by calcitonin measurement in fine-needle aspiration biopsy specimens. Thyroid 2007;17:635-638.
56. Goldfarb M, Gondek SS, Sanchez X, Lew JI. Clinic-based ultrasound can predict malignancy in pediatric thyroid nodules. Thyroid 2012 Apr 18. Epub ahead of print
57. Yoon JH, Kwak JY, Moon HJ, Kim MJ, Kim EK. The diagnostic accuracy of ultrasound-guided fine-needle aspiration biopsy and the sonographic differences between benign and malignant thyroid nodules 3 cm or larger. Thyroid 2011;21:993-1000. Epub 2011 Aug 11
58. Kabaker AS, Tublin ME, Nikiforov YE, Armstrong MJ, Hodak S, Stang MT, McCoy KL, Carty SE, Yip L. Suspicious Ultrasound Characteristics Predict BRAF V600E-Positive Papillary Thyroid Carcinoma. Thyroid 2012 Feb 23. Epub ahead of print
59. de los Santos ET, Mazzaferri EL. Thyrotoxicosis. Results and risks of current therapy. Postgrad Med 1990;87:277-278.
60. Corrias A, Mussa A, Wasniewska M, Segni M, Cassio A, Salerno M, Gastaldi R, Vigone MC, Bal M, Matarazzo P, Weber G, De Luca F. Levothyroxine treatment in pediatric benign thyroid nodules. Horm Res Paediatr 2011;75:246-251. Epub 2010 Dec 7
61. Chang YW, Hong HS, Choi DL. Sonography of the pediatric thyroid: a pictorial essay. J Clin Ultrasound 2009;37:149-157.
62. Babcock DS. Thyroid disease in the pediatric patient: emphasizing imaging with sonography. Pediatr Radiol 2006;36:299-308.
63. Rago T, Vitti P. Role of thyroid ultrasound in the diagnostic evaluation of thyroid nodules. Best Pract Res Clin Endocrinol Metab 2008;22:913-928.
64. Rago T, Scutari M, Santini C, Loiacono V, Piaggi P, Di Coscio G, Basolo, Berti, Pinchera A, Vitti P. Real-time elastosonography: useful tool for refining the presurgical diagnosis in thyroid nodules with indeterminate or nondiagnostic cytology. J Clin Endocrinol Metab 2010;95:5274-5280. Epub 2010 Sep 1
65. Stevens C, Lee JK, Sadatsafavi M, Blair GK. Pediatric thyroid fineneedle aspiration cytology: a meta-analysis. J Pediatr Surg 2009;44:2184-2191.
66. Roy R, Kouniavsky G, Schneider E, Allendorf JD, Chabot JA, Logerfo K, Dackiw A, Colombani P, Zeiger MA, Lee JA. Predictive factors of malignancy in pediatric thyroid nodules. Surgery 2011;150:1228-1233.
67. Altincikk A, Demir K, Abaci A, Böber E, Büyükgebiz A. Fine-needle aspiration biopsy in the diagnosis and follow-up of thyroid nodules in childhood. J Clin Res Pediatr Endocrinol 2010;2:78-80.
68. Wiersinga WM. Management of thyroid nodules in children and adolescents. Hormones (Athens) 2007;6:194-199.
69. Dinauer C, Francis GL. Thyroid cancer in children. Endocrinol Metab Clin North Am 2007;36:779-806.
70. Gharib H. Changing concepts in the diagnosis and management of thyroid nodules. Endocrinol Metab Clin North Am 1997;26:777-800.
71. Gutman PD, Henry M. Fine needle aspiration cytology of the thyroid. Clin Lab Med 1998;18:461-482.
72. Hung W. Solitary thyroid nodules in 93 children and adolescents. a 35-years experience. Horm Res 1999;52:15-18.
73. Degnan BM, McClellan DR, Francis GL. An analysis of fineneedle aspiration biopsy of the thyroid in children and adolescents. J Pediatr Surg 1996;31:903-907.
74. Feinmesser R, Lubin E, Segal K, Noyek A. Carcinoma of the thyroid in children-a review. J Pediatr Endocrinol Metab 1997;10:561-568.
75. Gharib H, Mazzaferri EL. Thyroxine suppressive therapy in patients with nodular thyroid disease. Ann Intern Med 1998;128:386-394.
76. Giuffrida D, Gharib H. Controversies in the management of cold, hot, and occult thyroid nodules. Am J Med 1995;99:642-650.
77. Papini E, Guglielmi R, Bianchini A, Crescenzi A, Taccogna S, Nardi F, Panunzi C, Rinaldi R, Toscano V, Pacella CM. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab 2002;87:1941-1946.
78. Gandolfi P, Frisina A, Raffa M, Renda F, Rocchetti O, Ruggeri C, Tombolini A. The incidence of thyroid carcinoma in multinodular goiter: retrospective analysis. Acta Biomed 2004;75:114-117.
79. Papotti M, Volante M, Saggiorato E, Deandreis D, Veltri A, Orlandi F. Role of galectin-3 immunodetection in the cytological diagnosis of thyroid cystic papillary carcinoma. Eur J Endocrinol 2002;147:515-521.
80. Hung W, Sarlis NJ. Current controversies in the management of pediatric patients with well-differentiated nonmedullary thyroid cancer: a review. Thyroid 2002;12:683-702.
81. Orlandi A, Puscar A, Capriata E, Fideleff H. Repeated fine-needle aspiration of the thyroid in benign nodular thyroid disease: critical evaluation of long-term follow-up. Thyroid 2005;15:274-278.
82. Castro MR, Gharib H. Continuing controversies in the management of thyroid nodules. Ann Intern Med 2005;142:926-931.
83. Sclabas GM, Staerkel GA, Shapiro SE, Fornage BD, Sherman SI, Vassillopoulou-Sellin R, Lee JE, Evans DB. Fine-needle aspiration of the thyroid and correlation with histopathology in a contemporary series of 240 patients. Am J Surg 2003;186:702-709.
84. Mijović T, Rochon L, Gologan O, Hier MP, Black MJ, Young J, Payne RJ. Fine-needle aspiration biopsies in the management of indeterminate follicular and Hurthle cell thyroid lesions. Otolaryngol Head Neck Surg 2009;140:715-719. Epub 2009 Mar 12
85. Mehanna HM, Jain A, Morton RP, Watkinson J, Shaha A. Investigating the thyroid nodule. BMJ 2009;338:733. Epub 2009 Mar 13
86. Unlütürk U, Erdoǧan MF, Demir O, Güllü S, Başkal N. Ultrasound elastography is not superior to grayscale ultrasound in predicting malignancy in thyroid nodules. Thyroid 2012;22:1031-1038. Epub 2012 Aug 9
87. Lippolis PV, Tognini S, Materazzi G, Polini A, Mancini R, Ambrosini CE, Dardano A, Basolo V, Seccia M, Miccoli Monzani. Is elastography actually useful in the presurgical selection of thyroid nodules with indeterminate cytology? J Clin Endocrinol Metab 2011;96:1826-1830. Epub 2011 Aug 24
88. Saggiorato E, De Pompa R, Volante M, Cappia S, Arecco F, Dei Tos A, Orlandi F, Papotti M. Characterization of thyroid 'follicular neoplasms' in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application. Endocr Relat Cancer 2005;12:305-317.
89. Raggio E, Camandona M, Solerio D, Martino P, Franchello A, Orlandi F, Gasparri G. The diagnostic accuracy of the immunohistochemical markers in the preoperative evaluation of follicular thyroid lesions. J Endocrinol Invest 2009;33:378-381.
90. Saggiorato E, Cappia S, De Giuli F, Mussa A, Pancani G, Caraci C, Angeli A, Orlandi Galectin-3 as a presurgical immunocytodiagnostic marker of minimally invasive follicular thyroid carcinoma. J Clin Endocrinol Metab 2001;86:5152-5158.
91. Cochand-Priollet B, Dahan H, Laloi-Michelin M, Polivka M, Saada M, Herman P, Guillausseau PJ, Hamzi L, Poté N, Sarfati E, Wassef M, Combe H, Raulic-Raimond D, Chedin P, Medeau V, Casanova D, Kania R. Immunocytochemistry with cytokeratin 19 and antihuman mesothelial cell antibody (HBME1) increases the diagnostic accuracy of thyroid fine-needle aspirations: preliminary report of 150 liquid-based fine-needle aspirations with histological control. Thyroid 2011;21:1067-1073. Epub 2011 Aug 29
92. Nikiforov YE, Ohori N, Hodak SP, Carty SE, LeBeau SO, Ferris RL, Yip L, Seethala RR, Tublin ME, Stang MT, Coyne C, Johnson JT, Stewart AF, Nikiforova MN. Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab 2011;96:3390-3397. Epub 2011 Aug 31
93. Li H, Robinson KA, Anton B, Saldanha IJ, Ladenson PW. Cost effectiveness of a novel molecular test for cytologically indeterminate thyroid nodules. J Clin Endocrinol Metab 2011;96:1719-1726. Epub 2011 Aug 24
94. Yip L, Farris C, Kabaker AS, Hodak SP, Nikiforova MN, McCoy KL, Stang MT, Smith KJ, Nikiforov YE, Carty SE. Cost impact of molecular testing for indeterminate thyroid nodule fine-needle aspiration biopsies. J Clin Endocrinol Metab 2012;97:1905-1912. Epub 2012 Mar 14
95. Deandreis D, Al Ghuzlan A, Auperin A, Vielh P, Caillou B, Chami L, Lumbroso J, Travagli JP, Hartl D, Baudin E, Schlumberger M, Leboulleux S. Is (18)F-fluorodeoxyglucose-PET/CT useful for the presurgical characterization of thyroid nodules with indeterminate fine needle aspiration cytology? Thyroid 2012;22:165-172. Epub 2012 Jan 18